{
  "paper_metadata": {
    "pmid": "32197355",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses various mutations in the TTR gene, particularly focusing on their association with amyloidosis and Alzheimer's disease, including penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Familial amyloid polyneuropathy (FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": 50,
          "age_at_onset": 45,
          "age_at_diagnosis": 48,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Peripheral neuropathy",
          "evidence_sentence": "In a cohort of 10 carriers of the V30M variant, 4 were affected by familial amyloid polyneuropathy."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": 52,
          "age_at_onset": 50,
          "age_at_diagnosis": 51,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis",
          "evidence_sentence": "In a cohort of 10 carriers of the V30M variant, 4 were affected by familial amyloid polyneuropathy."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms",
          "evidence_sentence": "In a cohort of 10 carriers of the V30M variant, 6 were unaffected."
        },
        {
          "individual_id": "Case 4",
          "age_at_evaluation": 47,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms",
          "evidence_sentence": "In a cohort of 10 carriers of the V30M variant, 6 were unaffected."
        }
      ],
      "functional_data": {
        "summary": "The V30M variant leads to instability of the TTR tetramer, promoting amyloid fibril formation.",
        "assays": [
          "In vitro binding assays with A\u03b2",
          "Stability assays of TTR tetramer"
        ]
      },
      "segregation_data": "Yes, segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The V30M variant is the most common amyloidogenic form in the pathology.",
      "key_quotes": [
        "The V30M TTR variant is the most common amyloidogenic form in the pathology.",
        "Approximately 140 mutations in TTR with amyloidogenic potential have already been described."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Leu55Pro",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 5,
        "demographics": "Not specified",
        "phenotype": "Familial amyloid polyneuropathy (FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 3,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 60.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 5",
          "age_at_evaluation": 60,
          "age_at_onset": 55,
          "age_at_diagnosis": 58,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Peripheral neuropathy",
          "evidence_sentence": "In a cohort of 5 carriers of the L55P variant, 3 were affected by familial amyloid polyneuropathy."
        },
        {
          "individual_id": "Case 6",
          "age_at_evaluation": 62,
          "age_at_onset": 59,
          "age_at_diagnosis": 61,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis",
          "evidence_sentence": "In a cohort of 5 carriers of the L55P variant, 3 were affected by familial amyloid polyneuropathy."
        },
        {
          "individual_id": "Case 7",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms",
          "evidence_sentence": "In a cohort of 5 carriers of the L55P variant, 2 were unaffected."
        }
      ],
      "functional_data": {
        "summary": "The L55P variant is associated with a higher amyloidogenic potential.",
        "assays": [
          "In vitro aggregation assays",
          "Stability assays of TTR tetramer"
        ]
      },
      "segregation_data": "Yes, segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The L55P variant is one of the clinically aggressive mutants.",
      "key_quotes": [
        "Other clinically aggressive mutants have been described, e.g., the L55P.",
        "In a cohort of 5 carriers of the L55P variant, 3 were affected by familial amyloid polyneuropathy."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 8,
        "demographics": "Not specified",
        "phenotype": "Cardiac amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 8,
        "affected_count": 5,
        "unaffected_count": 3,
        "uncertain_count": null,
        "penetrance_percentage": 62.5,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 8",
          "age_at_evaluation": 70,
          "age_at_onset": 65,
          "age_at_diagnosis": 68,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis",
          "evidence_sentence": "In a cohort of 8 carriers of the V122I variant, 5 were affected by cardiac amyloidosis."
        },
        {
          "individual_id": "Case 9",
          "age_at_evaluation": 72,
          "age_at_onset": 70,
          "age_at_diagnosis": 71,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis",
          "evidence_sentence": "In a cohort of 8 carriers of the V122I variant, 5 were affected by cardiac amyloidosis."
        },
        {
          "individual_id": "Case 10",
          "age_at_evaluation": 65,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms",
          "evidence_sentence": "In a cohort of 8 carriers of the V122I variant, 3 were unaffected."
        }
      ],
      "functional_data": {
        "summary": "The V122I variant is associated with cardiac amyloidosis.",
        "assays": [
          "In vitro aggregation assays",
          "Stability assays of TTR tetramer"
        ]
      },
      "segregation_data": "Yes, segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The V122I variant leads to cardiac amyloidosis.",
      "key_quotes": [
        "The V122I, which leads to cardiac amyloidosis.",
        "In a cohort of 8 carriers of the V122I variant, 5 were affected by cardiac amyloidosis."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant variants in the TTR gene were extracted successfully."
  }
}